[go: up one dir, main page]

EA200601176A1 - 3-цианохинолиновые производные с антипролиферативной активностью - Google Patents

3-цианохинолиновые производные с антипролиферативной активностью

Info

Publication number
EA200601176A1
EA200601176A1 EA200601176A EA200601176A EA200601176A1 EA 200601176 A1 EA200601176 A1 EA 200601176A1 EA 200601176 A EA200601176 A EA 200601176A EA 200601176 A EA200601176 A EA 200601176A EA 200601176 A1 EA200601176 A1 EA 200601176A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cyanohinoline
derivatives
antiproliferative activity
compounds
formula
Prior art date
Application number
EA200601176A
Other languages
English (en)
Inventor
Эдди Жан Эдгар Фрейн
Петер Якобус Йоханнес Антониус Бейнстерс
Кристоф Ван Эмелен
Вернер Констант Йохан Эмбрехтс
Тимоти Пьетро Сурен Перера
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684508&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200601176A1 publication Critical patent/EA200601176A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение относится к N-оксидным формам соединения формулы (I), их фармацевтически приемлемым солям и стереохимически изомерным формам. Соединения формулы (I) ингибируют тирозинкиназные ферменты.
EA200601176A 2003-12-18 2004-12-15 3-цианохинолиновые производные с антипролиферативной активностью EA200601176A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EPPCT/EP03/51059 2003-12-18
PCT/EP2004/053497 WO2005058318A1 (en) 2003-12-18 2004-12-15 3-cyano-quinoline derivatives with antiproliferative activity

Publications (1)

Publication Number Publication Date
EA200601176A1 true EA200601176A1 (ru) 2006-10-27

Family

ID=34684508

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601176A EA200601176A1 (ru) 2003-12-18 2004-12-15 3-цианохинолиновые производные с антипролиферативной активностью

Country Status (22)

Country Link
US (4) US7655642B2 (ru)
EP (1) EP1696914B1 (ru)
JP (1) JP4892353B2 (ru)
KR (1) KR101158440B1 (ru)
CN (1) CN1893944B (ru)
AR (1) AR047060A1 (ru)
AT (1) ATE446750T1 (ru)
AU (1) AU2004298784B2 (ru)
BR (1) BRPI0417609B8 (ru)
CA (1) CA2549728C (ru)
DE (1) DE602004023876D1 (ru)
EA (1) EA200601176A1 (ru)
ES (1) ES2335216T3 (ru)
IL (1) IL176358A (ru)
MX (1) MXPA06007018A (ru)
NO (1) NO337622B1 (ru)
NZ (1) NZ547795A (ru)
SG (1) SG151288A1 (ru)
TW (2) TWI389890B (ru)
UA (1) UA83880C2 (ru)
WO (1) WO2005058318A1 (ru)
ZA (1) ZA200604971B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06007018A (es) 2003-12-18 2006-08-31 Janssen Pharmaceutica Nv Derivados de 3-ciano-quinolino con actividad anti-proliferativa.
WO2005058913A1 (en) 2003-12-18 2005-06-30 Janssen Pharmaceutica N.V. Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents
NI200700147A (es) 2004-12-08 2019-05-10 Janssen Pharmaceutica Nv Derivados de quinazolina inhibidores de cinasas dirigidos a multip
JO3088B1 (ar) * 2004-12-08 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف
MY169441A (en) 2004-12-08 2019-04-11 Janssen Pharmaceutica Nv 2,4, (4,6) pyrimidine derivatives
US10517876B2 (en) 2005-11-16 2019-12-31 Cti Biopharma Corp. Oxygen linked pyrimidine derivatives
PH12012501003B1 (en) * 2005-11-16 2018-04-06 Cti Biopharma Corp Oxygen linked pyrimidine derivatives
AU2007274284B2 (en) * 2006-07-13 2012-04-26 Janssen Pharmaceutica N.V. Mtki quinazoline derivatives
EP2123627B1 (en) * 2007-01-19 2013-11-20 Ube Industries, Ltd. Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group
EP2170827B1 (en) * 2007-06-21 2013-08-14 Janssen Pharmaceutica, N.V. Indolin-2-ones and aza-indolin-2-ones
ES2562218T3 (es) 2007-07-27 2016-03-03 Janssen Pharmaceutica, N.V. Pirrolopirimidinas útiles para el tratamiento de enfermedades proliferativas
CN102127087B (zh) * 2011-01-21 2012-07-04 江苏先声药物研究有限公司 喹唑啉衍生物
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
KR20180086187A (ko) 2015-10-05 2018-07-30 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028613A (en) 1990-02-16 1991-07-02 Repligen Corporation Novel pyrroloquinoline alkaloids and methods of use
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
UA73073C2 (ru) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Замещенные 3-циан хинолины
ES2211175T3 (es) 1998-09-29 2004-07-01 Wyeth Holdings Corporation Inhibidores de proteinas de tipo tirosina quinasas a base de 3-cianoquinolinas sustituidas.
US6288082B1 (en) * 1998-09-29 2001-09-11 American Cyanamid Company Substituted 3-cyanoquinolines
IL164167A0 (en) * 2002-03-30 2005-12-18 Boehringer Ingelheim Pharma 4-(N-phenylamino)-quinazolines/ quinolines as tyrosine kinase inhibitors
PA8603801A1 (es) * 2003-05-27 2004-12-16 Janssen Pharmaceutica Nv Derivados de la quinazolina
MXPA06007018A (es) 2003-12-18 2006-08-31 Janssen Pharmaceutica Nv Derivados de 3-ciano-quinolino con actividad anti-proliferativa.

Also Published As

Publication number Publication date
MXPA06007018A (es) 2006-08-31
ES2335216T3 (es) 2010-03-23
IL176358A0 (en) 2006-10-05
HK1095742A1 (en) 2007-05-18
WO2005058318A1 (en) 2005-06-30
BRPI0417609A (pt) 2007-04-10
AU2004298784A1 (en) 2005-06-30
US9040511B2 (en) 2015-05-26
DE602004023876D1 (de) 2009-12-10
ZA200604971B (en) 2009-05-27
ATE446750T1 (de) 2009-11-15
US8778920B2 (en) 2014-07-15
CN1893944B (zh) 2011-07-06
TW201132628A (en) 2011-10-01
TWI389890B (zh) 2013-03-21
CN1893944A (zh) 2007-01-10
US20080139601A1 (en) 2008-06-12
US9365517B2 (en) 2016-06-14
NO20063324L (no) 2006-07-18
KR20070005560A (ko) 2007-01-10
BRPI0417609B8 (pt) 2021-05-25
JP4892353B2 (ja) 2012-03-07
KR101158440B1 (ko) 2012-07-06
UA83880C2 (en) 2008-08-26
NO337622B1 (no) 2016-05-09
NZ547795A (en) 2009-07-31
US20100069424A1 (en) 2010-03-18
TWI374879B (en) 2012-10-21
SG151288A1 (en) 2009-04-30
US20130197022A1 (en) 2013-08-01
BRPI0417609B1 (pt) 2019-02-19
AR047060A1 (es) 2006-01-04
EP1696914B1 (en) 2009-10-28
IL176358A (en) 2010-06-16
US7655642B2 (en) 2010-02-02
JP2007514711A (ja) 2007-06-07
AU2004298784B2 (en) 2011-06-09
TW200530187A (en) 2005-09-16
US20140256948A1 (en) 2014-09-11
CA2549728C (en) 2015-07-21
CA2549728A1 (en) 2005-06-30
EP1696914A1 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
EA200500721A1 (ru) Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
NO20070514L (no) Pyrrolotriazin kinase inhibitorer
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
EA200700220A1 (ru) Имидазотриазины в качестве ингибиторов протеинкиназы
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
EA200700633A1 (ru) Производные замещённого анилина
NO20070529L (no) Kinazolindionderivater som parp-inhibitorer
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
DK1864975T3 (da) Nikotinamid-derivater anvendelige som P38-inhibitorer
NO20062763L (no) Pyrrolotriazinforbindelser som kinaseinhibitorer
ATE517896T1 (de) P38-kinase-inhibitoren
EA200601176A1 (ru) 3-цианохинолиновые производные с антипролиферативной активностью
ATE405266T1 (de) Monozyklische oder bizyklische carbozyklen und heterozyklen als hemmer von factor xa
CR9929A (es) Nuevos compuestos
SE0202463D0 (sv) Novel compounds
GB0308201D0 (en) Novel compounds
ATE468341T1 (de) Thienopyrazole
EA200801199A1 (ru) Ингибиторы киназы
ATE482212T1 (de) Pyrrolotriazinverbindungen
TW200628153A (en) Novel compounds
EA200801200A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы